by Eric Christianson | Jun 9, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Bupropion (Wellbutrin) is an antidepressant that is most commonly used as an alternative (or sometimes in combination) to SSRIs. In this post, I will share my most important bupropion clinical pearls as well as some things that may show up on your board exam! Seizure...
by Eric Christianson | Jun 5, 2024 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Integrase inhibitors have become a mainstay in many HIV patients’ medication regimens. While this is a very important drug class in the management of HIV, one should be aware that there are numerous drug interactiosn to be aware of. In this post, I will lay out...
by Eric Christianson | May 22, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
I have many patients who take garlic supplements. One of the interactions I remember learning in pharmacy school is that garlic has the potential to increase the risk of bleeding when taken in combination with blood-thinning medications such as warfarin, DOACs,...
by Eric Christianson | May 15, 2024 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Antibiotics are an essential tool to treat infections. I’ve seen a lot of drug interactions involving antibiotics that have led to anything from treatment failure to drug toxicity. In this blog post, I share my top 5 antibiotic drug interactions you are likely...
by Eric Christianson | May 12, 2024 | Clinical Pharmacy News and New Drug Updates, Gastrointestinal Medication and Disease State Clinical Pearls
On November 1, 2023, the U.S. Food and Drug Administration (FDA) approved VOQUEZNA® (vonoprazan) as a new treatment for the healing and maintenance of erosive esophagitis and the relief of heartburn associated with erosive esophagitis in adults. This FDA approval...
